Merchants Bancorp 2024 Q3 Filing Summary
Business Context and Reporting Period
This summary covers the Form 10-Q for Merchants Bancorp for the quarterly period ended September 30, 2024. The Company is a diversified bank holding company headquartered in Carmel, Indiana, operating through three primary segments: Multi-family Mortgage Banking, Mortgage Warehousing, and Banking. The Company completed the sale of its Farmers-Merchants Bank of Illinois branches in January 2024.
Key Financial Metrics
| Metric | Q3 2024 | Q3 2023 | 9M 2024 | 9M 2023 |
|---|---|---|---|---|
| Net Income | $61.3 million | $81.5 million | $224.7 million | $201.8 million |
| Diluted EPS | $1.17 | $1.68 | $4.45 | $4.06 |
| Total Assets | $18.7 billion | $16.5 billion | $18.7 billion | $16.5 billion |
| Net Interest Income | $132.8 million | $117.4 million | $388.0 million | $323.7 million |
| Net Interest Margin | 2.99% | 2.99% | 3.04% | 3.07% |
| Provision for Credit Losses | $6.9 million | $4.0 million | $21.6 million | $33.5 million |
| Allowance for Credit Losses (ACL) | $84.5 million | $66.9 million | $84.5 million | $66.9 million |
| Nonperforming Loans | $210.9 million (2.04% of loans) | $60.2 million (0.60% of loans) | $210.9 million | $60.2 million |
| Total Deposits | $12.9 billion | $14.1 billion | $12.9 billion | $14.1 billion |
| Total Borrowings | $3.6 billion | $0.96 billion | $3.6 billion | $0.96 billion |
| Shareholders' Equity | $1.94 billion | $1.63 billion | $1.94 billion | $1.63 billion |
Material Changes vs. Prior Period
- Net Income Decline (Q3): Net income decreased 25% year-over-year to $61.3 million. This was primarily driven by a $2.9 million increase in the provision for credit losses (due to specific reserves on two customers) and unfavorable fair value adjustments on derivatives and servicing rights.
- Asset Growth: Total assets increased 10% year-over-year to $18.7 billion, driven by growth in loans held for sale, warehouse loans, and multi-family financing.
- Funding Shift: Borrowings increased 270% year-over-year to $3.6 billion, primarily due to $2.6 billion in additional FHLB advances. This shift was a strategic move to utilize more cost-effective collateralized borrowing rather than brokered deposits, which decreased by 53% to $2.8 billion.
- Asset Quality Deterioration: Nonperforming loans increased significantly to $210.9 million (2.04% of total loans) from $60.2 million in Q3 2023. This increase is attributed to multi-family and healthcare borrowers facing higher payments due to elevated interest rates.
- Securitization Activity: In September 2024, the Company sold $629 million of healthcare bridge loans into a private securitization (REMIC), purchasing $535 million of senior securities classified as held to maturity to reduce capital requirements.
Guidance, Outlook, and Risks
- Outlook: Management expects credit quality to improve with recent reductions in interest rates. The Company maintains a strong liquidity position with $5.1 billion in unused borrowing capacity and liquid assets totaling $11.1 billion (59% of total assets).
- Capital Position: The Company remains "well capitalized" under regulatory frameworks. Common Equity Tier 1 capital ratio was 8.9% as of September 30, 2024.
- Risks:
- Interest Rate Sensitivity: The Company is asset-sensitive; rising rates generally expand net interest margin, while falling rates compress it. NII at Risk modeling shows a 14.2% increase in income for a +200 basis point rate shock.
- Credit Risk: Elevated nonperforming loans in the multi-family and healthcare sectors remain a key risk, though specific reserves have been established.
- Derivative Valuation: Volatility in fair value adjustments for derivatives and servicing rights continues to impact noninterest income and expense.
Key Facts for Investor Verification
- Specific Reserves: Verify the details of the $8.0 million increase in specific reserves related to two customers mentioned in the provision for credit losses.
- Nonperforming Loan Composition: Review the breakdown of the $210.9 million in nonperforming loans to assess concentration risk in multi-family and healthcare sectors.
- Derivative Impact: Monitor the volatility of fair value adjustments on interest rate floors and servicing rights, which caused a $23.8 million loss in other income for Q3 2024.
- Brokered Deposit Reduction: Confirm the sustainability of the shift from brokered deposits to FHLB borrowings and the associated cost savings.
- Preferred Stock Redemption: Note the redemption of Series A Preferred Stock in April 2024 and the upcoming floating rate reset for Series B Preferred Stock in October 2024.